Stocks TelegraphStocks Telegraph
Stock Ideas

ZYXI Company Profile and Key Details

NASDAQ : ZYXI

Zynex

$0.13
0.073+140.38%
Open: 4:00 PM
61
B-ESG ScoreESG Rating

Price Chart

Stock Price Today

Zynex, Inc. (ZYXI) stock surged +140.38%, trading at $0.13 on NASDAQ, up from the previous close of $0.05. The stock opened at $0.13, fluctuating between $0.13 and $0.13 in the recent session.

Stock Snapshot

0.052
Prev. Close
3.8M
Market Cap
0.125
Day Low
-0.05186721991701245
P/E Ratio
-2.41
EPS (TTM)
0.49
Cash Flow per Share
0.13
Open
30.39M
Number of Shares
0.125
Day High
51.82%
Free Float in %
1.37
Book Value
274.57K
Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing DateAccepted Date

Annual Report (10-k)

Filing DateAccepted Date

Stock Price History Chart

DateOpenHighLowCloseVolume
Dec 23, 20250.200.200.120.1310.44M
Dec 22, 20250.310.350.180.196.48M
Dec 19, 20250.260.330.240.299.36M
Dec 17, 20250.320.360.230.264.6M
Dec 16, 20250.340.400.270.349.15M
Dec 15, 20250.730.770.650.66540.68K
Dec 12, 20250.880.880.740.74791.52K
Dec 11, 20250.870.900.780.86435.8K
Dec 10, 20250.890.950.830.87998.33K
Dec 09, 20250.790.860.750.85676.76K
Dec 08, 20250.890.950.780.81774.14K
Dec 05, 20251.041.060.840.89792.38K
Dec 04, 20251.161.171.001.031.14M
Dec 03, 20251.131.351.131.161.45M
Dec 02, 20251.291.311.081.172.03M
Dec 01, 20251.211.501.211.236.66M
Nov 28, 20251.441.681.211.268.69M
Nov 26, 20250.722.100.701.59138.36M
Nov 25, 20250.700.800.690.741.33M
Nov 24, 20250.660.880.630.7312.22M

Contact Details

Englewood, CO 80112

United States

https://www.zynex.com303 703 4906

About Company

Zynex, Inc., through its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and neuromuscular electrical stimulation (NMES) device that is marketed to physicians and therapists by field sales representatives; NeuroMove, an electromyography triggered electrical stimulation device; InWave, an electrical stimulation product for the treatment of female urinary incontinence; and E-Wave, an NMES device. It also supplies private labeled products, including electrodes for the delivery of electrical current to the body, and batteries for use in electrotherapy products. In addition, the company distributes Comfortrac/Saunders for cervical traction, JetStream for hot/cold therapy, LSO Back Braces for lumbar support, and knee braces for knee support. Further, it offers Zynex Fluid Monitoring System (CM-1500), a fluid volume monitor, which is a non-invasive medical device for monitoring relative fluid volume changes used in operating and recovery rooms to detect fluid loss during surgery and internal bleeding during recovery; Zynex Wireless Fluid Monitoring System (CM-1600), a noninvasive monitoring device designed to measure relative changes in fluid volume in adult patients; NiCO CO-Oximeter, a laser-based noninvasive co-oximeter; and HemeOx tHb Oximeter, a laser-based total hemoglobin pulse oximeter. The company provides its products for use in pain management and control; stroke and spinal cord injury rehabilitation; hemodynamic monitoring; and pulse oximetry monitoring. It sells its products through direct sales force primarily in the United States. Zynex, Inc. was founded in 1996 and is headquartered in Englewood, Colorado.

Company Information

Employees1000
Beta1
Sales or Revenue$184.32M
5Y Sales Change%4.807%
Fiscal Year EndsDecember
SectorHealthcare
IndustryMedical - Distribution

Company Overview

Zynex, Inc. (NASDAQ:ZYXI) closed at $0.12 USD, gaining $0.07 (140.38%) from the previous close of $0.05. The stock is currently mid-range between its 52-week high and low $0.03 and $8.45. With a market capitalization of about $3.80 million, Zynex, Inc. is classified as a micro-cap and shows market-like volatility (beta ~1.00). Key stats such as the average daily volume over the past year has been around 7.25 million shares, volume is running light vs its 52-week average. Headquartered in Englewood, CO, Zynex, Inc. operates in the Healthcare sector and the Medical - Distribution industry. Led by CEO Steven Lewis Dyson, the company employs approximately 1,000 people and listed since February 25, 2004. Zynex, Inc., through its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation.

Technical Performance

Short-term trend indicators are bullishly aligned (SMA20 -83.72%, SMA50 -86.91%, SMA200 -93.1%). The stock’s 14-day RSI is 27.94 (weak momentum), while the ATR of 0.18 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -98.52% below its high and over 0.24% above its low.

Valuation Metrics

Zynex, Inc. trades at a P/E ratio of -0.05, slightly below the S&P 500 average, with a price-to-sales ratio of 0.04 and a price-to-book ratio of -0.09 indicating negative book value, which may reflect financial stress. The P/FCF stands at -0.18, also above market averages.

Dividend & Fair Value

Zynex, Inc. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $19.99. This means the shares are trading below this model’s fair value.

Earnings & Analyst Outlook

Analyst sentiment is neutral. Analyst rating data shows there are 0 Strong Buy ratings, 1 Buy ratings, 1 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $8.00 to $3.00. The high target offers 6566.67% upside. The low target suggests 2400.0% downside. The mean target is $5.50. This offers 4483.33% upside. Zynex, Inc. earnings surprise history is a mixed track record. The quarter that ended November 17, 2025, missed forecasts by 645.08%. The prior quarter beat by 146.15%. Over the last six quarters, Apple has recorded several small beats. These include -52.76% in July 25, 2024.

Financial & Profitability Overview

Over the trailing twelve months, Zynex generated $184.32M in revenue, or $5.10 per share. Gross margin was 79.19%, operating margin 5.85%, and net profit margin 5.28%. Returns are healthy, with ROA at 6.90% and ROE at 21.10%.
On valuation metrics, Zynex trades at a P/E of -0.05, P/S of 0.04 and P/B of -0.09. Liquidity is tight, with a current ratio of 0.47 and quick ratio of 0.32. Operationally, the company’s inventory turnover is 2.56 and cash conversion cycle is 16.26 days. Debt-to-equity is -1.73, supported by a cash flow-to-debt ratio of -0.29.

Quarterly Financial Highlights

For the quarter ended Dec 31, 2023, Zynex posted revenue of $184.32M, down slightly from $158.17M in the prior quarter. Gross profit was $145.96M (margin 79.19%). Operating income was $10.78M (margin 5.8%). Net income was$9.73M (EPS $0.27).
The company ended the quarter with $44.58M in cash and short-term investments, a total debt of $76.17M, and net debt of $31.59M. Total assets were $141.07M, with equity of $46.13M. Financials further reflected stability, with operating cash flow of $17.95M, free cash flow of $16.74M, and capital expenditures of - $1.21M.

Price Forecast & Outlook

Our AI price prediction model suggests that Zynex, Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected decline of -100.0%, with price expected at $0.00 by January 06, 2026, within a range of $0.00 to $0.36 3-Month Outlook: Projected fall of -100.0%, reaching $0.00 by March 23, 2026, with a range of $0.00 to $0.07. 1-Year Outlook: Projected loss of -28.0%, with price at $0.09 by December 23, 2026, within a range of $0.00 to $0.09.

Key Takeaways

currently trading near 52-week highs band. Short-term momentum has been negative over the last quarter, despite recent volatility. Valuation shows Zynex, Inc. trading at a premium to the broader market with a P/E of -0.05. Analyst sentiment is cautious, with the majority of ratings in Sector Perform territory and a mean price target of $17.95, suggesting 14260.0% upside. Our AI forecast model points to short-term weakness (-100.0% over two weeks), a medium-term fall (-100.0% over three months), and a longer-term loss (-28.0% over one year), with expected trading ranges indicating moderate volatility.

Frequently Asked Questions

What is the current Zynex, Inc. (ZYXI) stock price?
Zynex, Inc. (NASDAQ: ZYXI) stock price is $0.13 in the last trading session. During the trading session, ZYXI stock reached the peak price of $0.13 while $0.13 was the lowest point it dropped to. The percentage change in ZYXI stock occurred in the recent session was 140.38% while the dollar amount for the price change in ZYXI stock was $0.07.
ZYXI's industry and sector of operation?
The NASDAQ listed ZYXI is part of Medical - Distribution industry that operates in the broader Healthcare sector. Zynex, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Who are the executives of ZYXI?
Mr. Donald Gregg
Pres of Zynex Monitoring Solutions
Mr. Daniel J. Moorhead
Chief Financial Officer
Mr. Steve Fox
Vice President Of Sales
Mr. Neil Friery
Pres & Chief Operating Officer of Zynex Monitoring Solutions, Inc.
Mr. Joachim Sandgaard
Information Systems Mang.
Ms. Chelle Van Burkleo
Vice President of Sales
Mr. Dave Anttila
Director of HR
Ms. Anna Lucsok
Chief Operating Officer
Mr. Thomas Sandgaard
Founder, Pres, Chief Executive Officer & Chairman
How ZYXI did perform over past 52-week?
ZYXI's closing price is 300.64% higher than its 52-week low of $0.03 where as its distance from 52-week high of $8.45 is -98.52%.
How many employees does ZYXI have?
Number of ZYXI employees currently stands at 1,000.
Link for ZYXI official website?
Official Website of ZYXI is: https://www.zynex.com
How do I contact ZYXI?
ZYXI could be contacted at phone 303 703 4906 and can also be accessed through its website. ZYXI operates from 9655 Maroon Circle, Englewood, CO 80112, United States.
How many shares of ZYXI are traded daily?
ZYXI stock volume for the day was 274.57K shares. The average number of ZYXI shares traded daily for last 3 months was 7.25M.
What is the market cap of ZYXI currently?
The market value of ZYXI currently stands at $3.80M with its latest stock price at $0.13 and 30.39M of its shares outstanding.
logo

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep

stockstelegraph

Don't have an account?

stockstelegraph

Don't have an account?

stockstelegraph

Already have an account?

stockstelegraph
Smart Screening Tools for Exceptional Returns
stockstelegraph

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!
stockstelegraph